caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1639221690

Raymond DehaanO.D.

PRACTICELIGHTHOUSE VISION CARE, P.C.See all providers at this practice →
OptometryTillamook, ORI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Raymond Dehaan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
ARNESON, SHIRLEY1543
Pacific Cataract And Laser Institute, Inc., P.C.
Ambulatory Surgical Center · Tualatin, OR
1221
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,027
Unique beneficiaries
—
Total services
1,095
Distinct HCPCS
10
Medicare payment
$54K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 472 Optometry providers in OR — top quintile (cohort median 186).
PRESCRIBING · PART D · 2024
Total Rx claims
341
Beneficiaries
—
Total drug cost
$3K
Distinct drugs
4
Brand share
0.0%
Top prescribed drugs
Latanoprost179 claims
Brimonidine Tartrate74 claims
Timolol Maleate46 claims
Dorzolamide Hcl42 claims